These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411 [TBL] [Abstract][Full Text] [Related]
5. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan. Johnson JT; Neill KK; Davis DA J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697 [TBL] [Abstract][Full Text] [Related]
6. Employer drug benefit plans and spending on prescription drugs. Joyce GF; Escarce JJ; Solomon MD; Goldman DP JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957 [TBL] [Abstract][Full Text] [Related]
7. Incentive-based formularies. Thomas CP N Engl J Med; 2003 Dec; 349(23):2186-8. PubMed ID: 14657424 [No Abstract] [Full Text] [Related]
8. Impact of health plan design and management on retirees' prescription drug use and spending, 2001. Thomas CP; Wallack SS; Lee S; Ritter GA Health Aff (Millwood); 2002; Suppl Web Exclusives():W408-19. PubMed ID: 12703602 [TBL] [Abstract][Full Text] [Related]
9. Prescription drugs: issues of cost, coverage, and quality. Copeland C EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445 [TBL] [Abstract][Full Text] [Related]
10. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share. Cecil WT; Barnes J; Shea T; Coulter SL J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845 [TBL] [Abstract][Full Text] [Related]
11. Specialty pharmacy management adjusts to new financial realities. Reinke T Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558 [No Abstract] [Full Text] [Related]
12. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans. Clark BE; Siracuse MV; Garis RI Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861 [TBL] [Abstract][Full Text] [Related]
14. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. Tseng CW; Brook RH; Keeler E; Mangione CM JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277 [TBL] [Abstract][Full Text] [Related]
15. The effect of incentive-based formularies on prescription-drug utilization and spending. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical formularies: the right formula for cost and utilization? Austin B Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009 [No Abstract] [Full Text] [Related]
17. Controlling prescription drug expenditures: a report of success. Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828 [TBL] [Abstract][Full Text] [Related]
18. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Motheral B; Fairman KA Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571 [TBL] [Abstract][Full Text] [Related]
19. Formulary management in the Department of Defense. Trice S; Devine J; Mistry H; Moore E; Linton A J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127 [TBL] [Abstract][Full Text] [Related]
20. Pharmacy benefits: new concepts in plan design. Goff VV NHPF Issue Brief; 2002 Mar; (772):1-16. PubMed ID: 11915906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]